This Article Full Text Full Text (PDF) All Versions of this Article: 40/5/1653    most recent STROKEAHA.108.539429v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kang, D.-W. Articles by Kim, J. S. Search for Related Content PubMed PubMed Citation Articles by Kang, D.-W. Articles by Kim, J. S. Related Collections Acute Cerebral Infarction Computerized tomography and Magnetic Resonance Imaging

(Stroke. 2009;40:1653.)
© 2009 American Heart Association, Inc.

Original Contributions

Inflammatory and Hemostatic Biomarkers Associated With Early Recurrent Ischemic Lesions in Acute Ischemic Stroke

Dong-Wha Kang, MD, PhD; Sung-Hee Yoo, RN, MS; Sail Chun, MD, PhD; Kyum-Yil Kwon, MD; Sun U. Kwon, MD, PhD; Jae-Young Koh, MD, PhD Jong S. Kim, MD, PhD

From the Departments of Neurology (D.-W.K., S.-H.Y., K.-Y.K., S.U.K., J.-Y.K., J.S.K.) and Laboratory Medicine (S.C.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Correspondence to Dong-Wha Kang, MD, PhD, Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, 388-1 Pungnap 2-dong, Songpa-gu, Seoul 138-736, Korea. E-mail dwkang{at}amc.seoul.kr

Background and Purpose— Early recurrent ischemic lesions (ERILs) on diffusion-weighted imaging after acute ischemic stroke have been suggested as a potential marker of early recurrent stroke. We hypothesized that biomarkers of inflammation or coagulation may be associated with the pathogenesis of ERILs and sought to investigate whether these biomarkers provide prognostic information on the risk of development of ERILs independently of clinical and imaging variables.

Methods— This prospective study enrolled 153 consecutive patients with acute ischemic stroke who underwent diffusion-weighted imaging within 24 hours and subsequently at 5 days after onset and whose plasma or serum for biomarkers (C-reactive protein, fibrinogen, D-dimer, tissue plasminogen activator, and plasminogen activator inhibitor-1) were collected within 24 hours of onset. Those receiving thrombolysis or interventional therapy were excluded. ERILs were defined as new ischemic lesions on 5-day diffusion-weighted imaging separate from the index stroke lesions, which were not accompanied by subsequent recanalization.

Results— ERILs were observed in 37 patients (24.2%). In univariate analysis, shorter time from onset to initial MRI (P=0.013), initial acute multiple infarcts (P<0.001), initial larger infarct volume (P=0.005), stroke subtype (P<0.001), elevated D-dimer (P=0.028), and anticoagulation after admission (P=0.001) were associated with ERILs. In multivariate analysis, initial acute multiple infarcts (OR, 16.60; 95% CI, 5.73 to 48.08), large artery atherosclerosis (OR, 4.62; 95% CI, 1.51 to 14.11), and log D-dimer (OR, 3.20; 95% CI, 1.14 to 9.00) remained independent predictors of ERILs.

Conclusion— These data suggest that elevated D-dimer level reflecting increase of thrombin generation and fibrin turnover may be an independent factor predicting ERILs.

Key Words: acute ischemic stroke • D-dimer • diffusion-weighted imaging • recurrence